Table 3 Treatment related conditions of HIV positive mothers who delivered in HUCSH, 2018
Characteristics | Frequency | Percent |
|---|---|---|
HAART exposure (n = 252) | ||
 No | 39 | 15.5 |
 Yes | 213 | 84.5 |
HAART initiated (n = 213) | ||
 During pregnancy | 23 | 10.8 |
 Before pregnancy | 190 | 89.2 |
ART Regimen (n = 213) | ||
 TDF-3TC-EFV | 135 | 63.4 |
 AZT-3TC-NVP | 53 | 24.9 |
 TDF-3TC-NVP | 25 | 11.7 |
Baseline CD4 count (cells/mm3) (n = 213) | ||
  < 200 | 69 | 32.4 |
 201–350 | 59 | 27.7 |
  > 350 | 85 | 39.9 |
CD4 level during the pregnancy (cells/mm3) (n = 213) | ||
  < 200 | 16 | 7.5 |
 201–350 | 37 | 17.4 |
  > 350 | 160 | 75.1 |
WHO clinical staging (n = 252) | ||
 Stage I | 217 | 86.1 |
 Stage II | 17 | 6.7 |
 Stage III | 11 | 4.4 |
 Stage IV | 7 | 2.8 |